163 related articles for article (PubMed ID: 15502019)
21. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
Zmuda K; Neofotistos D; Ts'ao CH
Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
[TBL] [Abstract][Full Text] [Related]
23. The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration for Cardiopulmonary Bypass in Severe Factor XII Deficiency.
Erkinaro T; Moilanen J; Lahtinen J; Mosorin M; Savolainen ER
J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):2031-2034. PubMed ID: 34130893
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.
Ichikawa J; Hagihira S; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
J Anesth; 2016 Dec; 30(6):923-928. PubMed ID: 27502398
[TBL] [Abstract][Full Text] [Related]
25. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.
Jessen LR; Wiinberg B; Jensen AL; Kjelgaard-Hansen M; Jensen KH; Pedersen LB; Kristensen AT
Vet Clin Pathol; 2008 Dec; 37(4):363-72. PubMed ID: 19055570
[TBL] [Abstract][Full Text] [Related]
26. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of two activated clotting time monitors during cardiac surgery.
Reich DL; Zahl K; Perucho MH; Thys DM
J Clin Monit; 1992 Jan; 8(1):33-6. PubMed ID: 1538250
[TBL] [Abstract][Full Text] [Related]
28. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
Martindale SJ; Shayevitz JR; D'Errico C
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
[TBL] [Abstract][Full Text] [Related]
29. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
30. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.
Nielsen VG
Anesth Analg; 2002 Dec; 95(6):1503-6, table of contents. PubMed ID: 12456408
[TBL] [Abstract][Full Text] [Related]
31. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
[TBL] [Abstract][Full Text] [Related]
32. Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
Srivastava AR; Banerjee A; Misra BB; Minhas H; Virmani S
J Card Surg; 2008; 23(3):239-45. PubMed ID: 18435639
[TBL] [Abstract][Full Text] [Related]
33. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
34. Effects of hypothermia on thrombelastography in patients undergoing cardiopulmonary bypass.
Kettner SC; Kozek SA; Groetzner JP; Gonano C; Schellongowski A; Kucera M; Zimpfer M
Br J Anaesth; 1998 Mar; 80(3):313-7. PubMed ID: 9623430
[TBL] [Abstract][Full Text] [Related]
35. Validation of viscoelastic coagulation tests during cardiopulmonary bypass.
Ortmann E; Rubino A; Altemimi B; Collier T; Besser MW; Klein AA
J Thromb Haemost; 2015 Jul; 13(7):1207-16. PubMed ID: 25903995
[TBL] [Abstract][Full Text] [Related]
36. [Reproducibility and interchangeability of the Thromboelastograph, Sonoclot and Hemochron activated coagulation time in cardiac surgery].
Forestier F; Bélisle S; Contant C; Harel F; Janvier G; Hardy JF
Can J Anaesth; 2001 Oct; 48(9):902-10. PubMed ID: 11606349
[TBL] [Abstract][Full Text] [Related]
37. Thromboprophylaxis With Heparin During Orthotopic Liver Transplantation: Comparison of Hepcon HMS Plus and Anti-Xa Assays for Low-Range Heparin.
Nicolau-Raducu R; Occhipinti E; Marshall T; Koveleskie J; Ganier D; Evans B; Daly W; Fish B; Cohen AJ; Reichman TW; Bruce D; Bohorquez H; Seal J; Ahmed E; Carmody I; Loss G; Rayburn J; Nossaman B
J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):575-581. PubMed ID: 27745797
[TBL] [Abstract][Full Text] [Related]
38. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
39. Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
Gilly G; Trusheim J
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1730-1732. PubMed ID: 27751763
[No Abstract] [Full Text] [Related]
40. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
